Home › Left Ventricular Dysfunction › Texas › Dallas
Left Ventricular Dysfunction clinical trials in Dallas, TX
3 studies for Left Ventricular Dysfunction are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
RecruitingPhase 2/3
- Children's Health-The Heart Center ( Site 0015), Dallas
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Children's Medical Center Dallas - Cardiology, Dallas
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
RecruitingPhase 3
- Children's Medical Center Dallas - Cardiology, Dallas
Left Ventricular Dysfunction trials in other cities
- New York City, NY4 studies
- Cleveland, OH4 studies
- Philadelphia, PA3 studies
- St. Louis, MO3 studies
- Ann Arbor, MI3 studies
- The Bronx, NY3 studies
- Pittsburgh, PA3 studies
- Houston, TX3 studies
- Boston, MA3 studies
- Aurora, CO3 studies
- Cincinnati, OH3 studies
- Atlanta, GA3 studies
Other studies in Dallas
- Breast Cancer55 studies
- Non-Small Cell Lung Cancer52 studies
- Metastatic Cancer42 studies
- Heart Failure42 studies
- Cancer (all types)37 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity30 studies
- Ovarian Cancer28 studies
- Lung Cancer27 studies
- Bladder Cancer27 studies
- Endometrial Cancer24 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.